HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donghua Xu Selected Research

Donghua Xu Research Topics

Disease

8Neoplasms (Cancer)
01/2021 - 07/2012
7Inflammation (Inflammations)
10/2020 - 03/2013
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2011
4Rheumatoid Arthritis
10/2020 - 01/2018
4Carcinogenesis
01/2020 - 03/2014
3Arthritis (Polyarthritis)
10/2020 - 01/2015
3Hepatocellular Carcinoma (Hepatoma)
10/2014 - 11/2012
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2017
2Type 2 Diabetes Mellitus (MODY)
03/2016 - 11/2014
1COVID-19
08/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2022
1Ankylosing Spondylitis
06/2021
1Ischemic Stroke
01/2021
1Cerebral Hemorrhage
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Stroke (Strokes)
01/2021
1Experimental Arthritis
10/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Pre-Eclampsia (Preeclampsia)
01/2019
1Alzheimer Disease (Alzheimer's Disease)
05/2016
1Peripheral Nervous System Diseases (PNS Diseases)
03/2016
1Hyperuricemia
03/2016
1Virus Diseases (Viral Diseases)
01/2015
1Gout
01/2015
1Gouty Arthritis
01/2015
1Stomach Neoplasms (Stomach Cancer)
03/2014
1Habitual Abortion (Recurrent Miscarriage)
09/2013
1Premature Obstetric Labor (Premature Labor)
10/2012

Drug/Important Bio-Agent (IBA)

12MicroRNAs (MicroRNA)IBA
01/2021 - 01/2015
4Uric Acid (Urate)IBA
05/2016 - 01/2015
3Circular RNAIBA
01/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2017
2EnzymesIBA
08/2022 - 01/2019
2Messenger RNA (mRNA)IBA
06/2021 - 01/2021
2ORALIT (ORS)IBA
01/2021 - 03/2014
2Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
01/2019 - 10/2014
2Long Noncoding RNAIBA
01/2019 - 01/2019
2Toll-Like Receptor 4IBA
01/2015 - 10/2014
1LipopolysaccharidesIBA
08/2022
1Phosphotransferases (Kinase)IBA
08/2022
1B-Cell Activating FactorIBA
08/2022
1TNF Receptor-Associated Factor 1IBA
08/2022
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
08/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2022
1ImmunosorbentsIBA
08/2022
1InterleukinsIBA
08/2022
1LigandsIBA
08/2022
1C-Reactive ProteinIBA
06/2021
1Interleukin-12 Subunit p40IBA
06/2021
1FilaminsIBA
01/2021
1Vascular Endothelial Growth Factor CIBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020
16-methyladenineIBA
01/2019
1Competitive Endogenous RNAIBA
01/2019
1Interferon LambdaIBA
01/2015
1AntioxidantsIBA
01/2015
1CytokinesIBA
01/2015
1Nitrogen DioxideIBA
11/2014
1Particulate MatterIBA
11/2014
1Air Pollutants (Pollutants, Air)IBA
11/2014
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
03/2014
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2013
1AntibodiesIBA
10/2012
1Biocompatible Materials (Biomaterials)IBA
07/2012
1HydrogelsIBA
07/2012
1Proteins (Proteins, Gene)FDA Link
07/2012
1glutathione S-transferase T1IBA
01/2011

Therapy/Procedure

2Therapeutics
01/2021 - 01/2017
2Radiofrequency Ablation
07/2013 - 11/2012
1Transplantation
08/2022
1Injections
07/2012